HealthNationalTop Headlines

AIIMS, Delhi has started the registration process for conducting the human trials of COVAXIN, today

Speaking exclusively, Dr. Rai said that the first dose of the vaccine is likely to be administered to the volunteers on this Thursday.

AIIMS, Delhi has started the registration process for conducting the human trials of COVAXIN, today. Principal Investigator for conducting these trials at one of the top medical institutes in the country, AIIMS Delhi , Dr. Sanjay Rai has said that the response for registration has been overwhelming.

Speaking exclusively, Dr. Rai said that the first dose of the vaccine is likely to be administered to the volunteers on this Thursday.

Tags

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button